Ocata Therapeutics Inc fka OCAT

[rocky301]

RECEO,


I guess it all comes down to do you think they will RS and dilute in order to get to the finish line if the trials are successful?


That question goes way beyond a yes or no answer. "Finish line" to me is commercializing the product. ACT is hoping to partner up at some time during the clinical trials to take on the long and expensive route to market. What form or when a partnership will occur will be largely dependent on the level of clinical results needed for a partner to step up. Right now our cash on hand should pay operating costs and trial costs through year end. If no partner exists by then I would assume the $21MM available from Socius would be tapped. The RS scenario, imo, will only be used to move to large exchange.